C. Lowry Barnes
Concepts (526)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthroplasty, Replacement, Knee | 57 | 2024 | 286 | 12.830 |
Why?
| Arthroplasty, Replacement, Hip | 52 | 2024 | 263 | 12.740 |
Why?
| Antibodies, Neutralizing | 10 | 2025 | 62 | 2.490 |
Why?
| Orthopedics | 10 | 2022 | 52 | 2.470 |
Why?
| Osteoarthritis, Knee | 11 | 2022 | 98 | 2.280 |
Why?
| Health Literacy | 5 | 2019 | 130 | 2.040 |
Why?
| Length of Stay | 18 | 2024 | 631 | 2.030 |
Why?
| Antibodies, Viral | 9 | 2025 | 93 | 1.920 |
Why?
| Humans | 151 | 2025 | 50419 | 1.910 |
Why?
| Reoperation | 14 | 2024 | 461 | 1.870 |
Why?
| Patient Readmission | 13 | 2024 | 229 | 1.820 |
Why?
| Knee Joint | 19 | 2023 | 165 | 1.810 |
Why?
| Pneumonia, Viral | 7 | 2020 | 169 | 1.770 |
Why?
| Coronavirus Infections | 7 | 2020 | 176 | 1.740 |
Why?
| Aged | 53 | 2025 | 9738 | 1.720 |
Why?
| Arthroplasty, Replacement | 5 | 2019 | 27 | 1.700 |
Why?
| Medicare | 17 | 2024 | 247 | 1.700 |
Why?
| Hip Prosthesis | 6 | 2021 | 73 | 1.690 |
Why?
| Analgesics, Opioid | 10 | 2024 | 577 | 1.680 |
Why?
| Air Pollution, Indoor | 5 | 2025 | 26 | 1.680 |
Why?
| Preoperative Care | 5 | 2018 | 170 | 1.610 |
Why?
| Retrospective Studies | 44 | 2024 | 6274 | 1.550 |
Why?
| Fungi | 4 | 2025 | 48 | 1.500 |
Why?
| Allergens | 5 | 2025 | 137 | 1.470 |
Why?
| Joint Instability | 4 | 2022 | 42 | 1.410 |
Why?
| United States | 29 | 2024 | 5005 | 1.400 |
Why?
| Pandemics | 11 | 2022 | 553 | 1.360 |
Why?
| Periprosthetic Fractures | 4 | 2022 | 11 | 1.320 |
Why?
| Postoperative Complications | 13 | 2024 | 1030 | 1.270 |
Why?
| Pain, Postoperative | 7 | 2024 | 163 | 1.250 |
Why?
| Respiratory Hypersensitivity | 2 | 2025 | 18 | 1.220 |
Why?
| Range of Motion, Articular | 8 | 2022 | 108 | 1.220 |
Why?
| Prosthesis-Related Infections | 6 | 2023 | 112 | 1.210 |
Why?
| Joint Diseases | 3 | 2018 | 41 | 1.200 |
Why?
| Critical Pathways | 3 | 2017 | 36 | 1.170 |
Why?
| Golf | 3 | 2023 | 9 | 1.170 |
Why?
| Patient Discharge | 14 | 2022 | 318 | 1.160 |
Why?
| Hip Dislocation | 2 | 2019 | 17 | 1.130 |
Why?
| Orthopedic Procedures | 6 | 2020 | 71 | 1.110 |
Why?
| Comprehension | 2 | 2018 | 111 | 1.070 |
Why?
| Patient Education as Topic | 4 | 2018 | 332 | 1.050 |
Why?
| Middle Aged | 39 | 2025 | 12579 | 1.030 |
Why?
| Antibodies, Bispecific | 2 | 2025 | 88 | 1.000 |
Why?
| Prosthesis Failure | 5 | 2020 | 110 | 0.960 |
Why?
| Male | 55 | 2025 | 25866 | 0.950 |
Why?
| Antigens, Fungal | 1 | 2025 | 25 | 0.940 |
Why?
| Osteoarthritis | 6 | 2023 | 59 | 0.910 |
Why?
| Immunoglobulin G | 4 | 2021 | 188 | 0.900 |
Why?
| Pain Management | 3 | 2016 | 180 | 0.900 |
Why?
| Female | 53 | 2025 | 27053 | 0.870 |
Why?
| Risk Factors | 18 | 2023 | 3712 | 0.840 |
Why?
| Hip | 2 | 2020 | 25 | 0.820 |
Why?
| Lordosis | 1 | 2022 | 4 | 0.790 |
Why?
| Opioid-Related Disorders | 5 | 2023 | 392 | 0.790 |
Why?
| Prosthesis Design | 4 | 2021 | 245 | 0.780 |
Why?
| Hospitals | 10 | 2024 | 170 | 0.780 |
Why?
| Kyphosis | 1 | 2022 | 15 | 0.780 |
Why?
| Knee | 3 | 2021 | 21 | 0.760 |
Why?
| Blood Transfusion | 3 | 2016 | 123 | 0.720 |
Why?
| Transurethral Resection of Prostate | 1 | 2021 | 10 | 0.720 |
Why?
| Prostatic Hyperplasia | 1 | 2021 | 39 | 0.700 |
Why?
| Immunoglobulin Fab Fragments | 1 | 2020 | 15 | 0.690 |
Why?
| Knee Prosthesis | 4 | 2023 | 55 | 0.690 |
Why?
| Aged, 80 and over | 14 | 2025 | 3233 | 0.680 |
Why?
| Housing | 3 | 2015 | 46 | 0.630 |
Why?
| Anesthesia, General | 4 | 2024 | 99 | 0.630 |
Why?
| Surgery Department, Hospital | 1 | 2019 | 4 | 0.620 |
Why?
| Diabetic Foot | 1 | 2019 | 48 | 0.620 |
Why?
| Bone Cements | 1 | 2019 | 30 | 0.620 |
Why?
| Polymethyl Methacrylate | 1 | 2019 | 26 | 0.620 |
Why?
| Societies, Medical | 2 | 2020 | 189 | 0.620 |
Why?
| Hip Joint | 2 | 2020 | 58 | 0.610 |
Why?
| Cost Savings | 2 | 2017 | 58 | 0.590 |
Why?
| Epitopes | 6 | 2025 | 60 | 0.590 |
Why?
| Comorbidity | 5 | 2018 | 621 | 0.590 |
Why?
| Arthroplasty | 4 | 2023 | 28 | 0.580 |
Why?
| Yoga | 1 | 2018 | 15 | 0.580 |
Why?
| Hospitals, Teaching | 2 | 2019 | 52 | 0.560 |
Why?
| Inpatients | 7 | 2020 | 194 | 0.550 |
Why?
| Cryoelectron Microscopy | 5 | 2025 | 11 | 0.550 |
Why?
| Clinical Protocols | 1 | 2017 | 111 | 0.540 |
Why?
| Postoperative Period | 6 | 2018 | 171 | 0.540 |
Why?
| Dust | 2 | 2015 | 22 | 0.540 |
Why?
| Arthritis, Infectious | 3 | 2023 | 44 | 0.530 |
Why?
| Quadriceps Muscle | 4 | 2022 | 46 | 0.530 |
Why?
| Patient Navigation | 1 | 2016 | 12 | 0.530 |
Why?
| Anti-Bacterial Agents | 4 | 2023 | 751 | 0.520 |
Why?
| Antifibrinolytic Agents | 1 | 2016 | 16 | 0.510 |
Why?
| Tranexamic Acid | 1 | 2016 | 15 | 0.510 |
Why?
| Early Ambulation | 1 | 2016 | 5 | 0.510 |
Why?
| Musculoskeletal Pain | 1 | 2016 | 7 | 0.510 |
Why?
| Caregivers | 1 | 2018 | 223 | 0.510 |
Why?
| Adult | 25 | 2025 | 13561 | 0.490 |
Why?
| Publishing | 1 | 2016 | 40 | 0.480 |
Why?
| Quality of Health Care | 1 | 2017 | 183 | 0.480 |
Why?
| Periodicals as Topic | 1 | 2016 | 58 | 0.470 |
Why?
| Analgesia, Epidural | 1 | 2015 | 27 | 0.460 |
Why?
| Bupivacaine | 1 | 2015 | 28 | 0.460 |
Why?
| Treatment Outcome | 11 | 2024 | 5265 | 0.460 |
Why?
| Narcotics | 3 | 2020 | 113 | 0.450 |
Why?
| Intermittent Pneumatic Compression Devices | 1 | 2014 | 2 | 0.450 |
Why?
| Epilepsy | 1 | 2016 | 181 | 0.430 |
Why?
| Exercise | 1 | 2018 | 513 | 0.430 |
Why?
| Odds Ratio | 8 | 2019 | 550 | 0.430 |
Why?
| Knee Injuries | 2 | 2023 | 29 | 0.410 |
Why?
| Venous Thromboembolism | 1 | 2014 | 74 | 0.410 |
Why?
| Shoulder Joint | 2 | 2009 | 38 | 0.400 |
Why?
| Popliteal Artery | 2 | 2002 | 30 | 0.390 |
Why?
| Air Pollutants | 1 | 2013 | 64 | 0.390 |
Why?
| Activities of Daily Living | 3 | 2023 | 175 | 0.380 |
Why?
| Health Expenditures | 3 | 2017 | 69 | 0.380 |
Why?
| Antibodies, Monoclonal | 7 | 2025 | 460 | 0.380 |
Why?
| Sleep Disorders, Circadian Rhythm | 2 | 2021 | 4 | 0.380 |
Why?
| Work Schedule Tolerance | 2 | 2021 | 5 | 0.380 |
Why?
| Osteonecrosis | 2 | 2022 | 34 | 0.370 |
Why?
| Asthma | 5 | 2015 | 303 | 0.360 |
Why?
| Lower Extremity | 3 | 2023 | 92 | 0.340 |
Why?
| Acetabulum | 3 | 2020 | 38 | 0.330 |
Why?
| Pain | 4 | 2024 | 386 | 0.330 |
Why?
| Models, Molecular | 5 | 2021 | 333 | 0.320 |
Why?
| Tibial Fractures | 2 | 2021 | 31 | 0.310 |
Why?
| Cost-Benefit Analysis | 3 | 2021 | 263 | 0.310 |
Why?
| Osteoarthritis, Hip | 3 | 2019 | 26 | 0.310 |
Why?
| Cross-Sectional Studies | 5 | 2016 | 1601 | 0.310 |
Why?
| Arthroscopy | 1 | 2009 | 41 | 0.300 |
Why?
| Fee-for-Service Plans | 2 | 2020 | 18 | 0.300 |
Why?
| B-Lymphocytes | 4 | 2021 | 171 | 0.290 |
Why?
| Movement | 4 | 2021 | 82 | 0.290 |
Why?
| Animals | 10 | 2025 | 13063 | 0.280 |
Why?
| Patient Satisfaction | 2 | 2020 | 276 | 0.280 |
Why?
| Humidity | 1 | 2007 | 3 | 0.280 |
Why?
| Viscosupplements | 2 | 2017 | 14 | 0.280 |
Why?
| Hyaluronic Acid | 2 | 2017 | 33 | 0.270 |
Why?
| Respiratory Tract Diseases | 1 | 2007 | 26 | 0.270 |
Why?
| Young Adult | 8 | 2021 | 4075 | 0.260 |
Why?
| Risk | 2 | 2017 | 325 | 0.250 |
Why?
| Femoral Fractures | 2 | 2023 | 41 | 0.250 |
Why?
| Mice | 7 | 2025 | 5659 | 0.250 |
Why?
| Mutation | 5 | 2021 | 1275 | 0.240 |
Why?
| Breast Neoplasms | 4 | 2024 | 1198 | 0.240 |
Why?
| Logistic Models | 3 | 2016 | 901 | 0.240 |
Why?
| Spores, Fungal | 1 | 2025 | 21 | 0.240 |
Why?
| Muscle Strength | 3 | 2022 | 127 | 0.240 |
Why?
| Physical Examination | 2 | 2019 | 94 | 0.230 |
Why?
| Radiography | 6 | 2019 | 482 | 0.230 |
Why?
| Dexmedetomidine | 1 | 2025 | 22 | 0.230 |
Why?
| Psychomotor Agitation | 1 | 2025 | 52 | 0.230 |
Why?
| Hip Fractures | 2 | 2023 | 46 | 0.230 |
Why?
| Delirium | 1 | 2025 | 51 | 0.230 |
Why?
| Mice, Inbred BALB C | 1 | 2025 | 293 | 0.230 |
Why?
| Single-Cell Analysis | 1 | 2024 | 63 | 0.220 |
Why?
| Arthralgia | 3 | 2022 | 45 | 0.220 |
Why?
| Hypnotics and Sedatives | 1 | 2025 | 75 | 0.220 |
Why?
| Acromioclavicular Joint | 1 | 2004 | 4 | 0.220 |
Why?
| Ligaments, Articular | 1 | 2004 | 8 | 0.220 |
Why?
| Adolescent | 9 | 2021 | 6453 | 0.220 |
Why?
| Hospital Mortality | 2 | 2016 | 411 | 0.220 |
Why?
| Public Opinion | 2 | 2021 | 21 | 0.220 |
Why?
| Femur | 2 | 2021 | 130 | 0.210 |
Why?
| Antibiotic Prophylaxis | 1 | 2023 | 64 | 0.210 |
Why?
| Reproducibility of Results | 3 | 2022 | 1181 | 0.210 |
Why?
| Poverty | 2 | 2015 | 207 | 0.210 |
Why?
| Environmental Exposure | 1 | 2025 | 201 | 0.210 |
Why?
| Fracture Fixation, Intramedullary | 2 | 2003 | 10 | 0.210 |
Why?
| Pulse | 1 | 2002 | 14 | 0.200 |
Why?
| Mechanotransduction, Cellular | 1 | 2023 | 39 | 0.200 |
Why?
| Bone Neoplasms | 1 | 2024 | 178 | 0.200 |
Why?
| Palliative Care | 1 | 2025 | 191 | 0.200 |
Why?
| Braces | 1 | 2002 | 9 | 0.200 |
Why?
| Bone Diseases, Metabolic | 1 | 2023 | 74 | 0.200 |
Why?
| Neuregulin-1 | 1 | 2002 | 3 | 0.190 |
Why?
| Bone Nails | 1 | 2002 | 11 | 0.190 |
Why?
| Myositis | 1 | 2022 | 17 | 0.190 |
Why?
| Gait | 2 | 2021 | 89 | 0.190 |
Why?
| Outpatients | 2 | 2020 | 121 | 0.190 |
Why?
| Pelvis | 1 | 2022 | 66 | 0.190 |
Why?
| Neutralization Tests | 4 | 2023 | 20 | 0.190 |
Why?
| Pain Measurement | 3 | 2019 | 271 | 0.190 |
Why?
| Adenosine Triphosphatases | 1 | 2002 | 88 | 0.190 |
Why?
| Osteocytes | 1 | 2024 | 225 | 0.190 |
Why?
| Databases, Factual | 4 | 2019 | 676 | 0.190 |
Why?
| Antibody Affinity | 1 | 2021 | 7 | 0.190 |
Why?
| Injections, Intra-Articular | 3 | 2017 | 37 | 0.190 |
Why?
| Cost of Illness | 1 | 2022 | 115 | 0.190 |
Why?
| Metal-on-Metal Joint Prostheses | 1 | 2021 | 5 | 0.180 |
Why?
| Anemia, Sickle Cell | 1 | 2022 | 95 | 0.180 |
Why?
| Lumbar Vertebrae | 1 | 2022 | 102 | 0.180 |
Why?
| Cell Nucleus | 1 | 2002 | 183 | 0.180 |
Why?
| Fractures, Open | 2 | 2002 | 9 | 0.180 |
Why?
| Multiple Myeloma | 1 | 2016 | 2990 | 0.180 |
Why?
| Vaccines, Synthetic | 1 | 2021 | 22 | 0.180 |
Why?
| Crowdsourcing | 1 | 2021 | 8 | 0.180 |
Why?
| Immunity, Humoral | 1 | 2021 | 22 | 0.180 |
Why?
| Receptors, Virus | 1 | 2020 | 24 | 0.180 |
Why?
| Posture | 1 | 2021 | 64 | 0.180 |
Why?
| Joints | 2 | 2018 | 18 | 0.180 |
Why?
| Femur Head Necrosis | 1 | 2020 | 18 | 0.170 |
Why?
| Dissociative Disorders | 1 | 2020 | 6 | 0.170 |
Why?
| Epitope Mapping | 1 | 2020 | 6 | 0.170 |
Why?
| Decompression, Surgical | 1 | 2020 | 48 | 0.170 |
Why?
| Adrenal Cortex Hormones | 2 | 2020 | 102 | 0.170 |
Why?
| Immunization, Passive | 1 | 2020 | 30 | 0.170 |
Why?
| Cross Reactions | 1 | 2020 | 40 | 0.170 |
Why?
| Politics | 1 | 2020 | 27 | 0.170 |
Why?
| Bariatric Surgery | 1 | 2021 | 42 | 0.170 |
Why?
| Polyethylene | 1 | 2020 | 18 | 0.170 |
Why?
| Carrier Proteins | 1 | 2002 | 297 | 0.170 |
Why?
| Diagnosis-Related Groups | 2 | 2017 | 18 | 0.170 |
Why?
| Obesity, Morbid | 1 | 2021 | 78 | 0.170 |
Why?
| Tobacco Smoke Pollution | 2 | 2014 | 48 | 0.170 |
Why?
| Host-Pathogen Interactions | 1 | 2021 | 134 | 0.170 |
Why?
| Leadership | 1 | 2020 | 100 | 0.160 |
Why?
| Foot Orthoses | 1 | 2019 | 5 | 0.160 |
Why?
| External Fixators | 1 | 2019 | 9 | 0.160 |
Why?
| Recombinant Proteins | 1 | 2020 | 477 | 0.160 |
Why?
| Fracture Healing | 2 | 1996 | 27 | 0.160 |
Why?
| Tobramycin | 1 | 2019 | 16 | 0.160 |
Why?
| Antiviral Agents | 1 | 2020 | 171 | 0.160 |
Why?
| After-Hours Care | 1 | 2019 | 12 | 0.160 |
Why?
| Hematologic Neoplasms | 1 | 2020 | 99 | 0.160 |
Why?
| Prostheses and Implants | 1 | 2019 | 55 | 0.150 |
Why?
| Sepsis | 1 | 2021 | 225 | 0.150 |
Why?
| Hospitals, University | 1 | 2019 | 75 | 0.150 |
Why?
| Postural Balance | 2 | 2021 | 57 | 0.150 |
Why?
| Multiple Sclerosis | 1 | 2019 | 64 | 0.150 |
Why?
| Vancomycin | 1 | 2019 | 78 | 0.150 |
Why?
| Ambulatory Surgical Procedures | 1 | 2019 | 54 | 0.150 |
Why?
| Rural Population | 1 | 2023 | 556 | 0.150 |
Why?
| Healthcare Disparities | 1 | 2022 | 280 | 0.150 |
Why?
| Exercise Test | 1 | 2019 | 131 | 0.150 |
Why?
| Medicaid | 2 | 2022 | 258 | 0.150 |
Why?
| Drug Prescriptions | 1 | 2019 | 98 | 0.150 |
Why?
| Rotation | 1 | 2018 | 43 | 0.150 |
Why?
| Recreation | 1 | 2018 | 20 | 0.150 |
Why?
| Microbial Sensitivity Tests | 1 | 2019 | 268 | 0.140 |
Why?
| Benzodiazepines | 1 | 2018 | 70 | 0.140 |
Why?
| Tramadol | 1 | 2018 | 30 | 0.140 |
Why?
| Guidelines as Topic | 1 | 2018 | 110 | 0.140 |
Why?
| Incidence | 3 | 2019 | 1027 | 0.140 |
Why?
| Body Mass Index | 2 | 2018 | 674 | 0.140 |
Why?
| Recovery of Function | 1 | 2018 | 191 | 0.140 |
Why?
| Subacute Care | 1 | 2017 | 5 | 0.140 |
Why?
| Academic Medical Centers | 1 | 2018 | 147 | 0.140 |
Why?
| Language | 1 | 2018 | 135 | 0.140 |
Why?
| Immunologic Memory | 3 | 2021 | 29 | 0.130 |
Why?
| Estrogen Receptor alpha | 3 | 2006 | 90 | 0.130 |
Why?
| Patient Safety | 1 | 2017 | 102 | 0.130 |
Why?
| Nut Hypersensitivity | 1 | 2016 | 3 | 0.130 |
Why?
| Cocos | 1 | 2016 | 2 | 0.130 |
Why?
| Football | 1 | 2018 | 72 | 0.130 |
Why?
| Fractures, Bone | 4 | 1992 | 110 | 0.130 |
Why?
| Nuts | 1 | 2016 | 8 | 0.130 |
Why?
| Time Factors | 5 | 2021 | 2933 | 0.130 |
Why?
| Hospitals, Community | 1 | 2016 | 19 | 0.130 |
Why?
| Social Support | 1 | 2018 | 264 | 0.130 |
Why?
| Costs and Cost Analysis | 1 | 2016 | 90 | 0.130 |
Why?
| Quality Improvement | 1 | 2018 | 215 | 0.130 |
Why?
| Anesthesia, Spinal | 1 | 2016 | 16 | 0.120 |
Why?
| Anemia | 1 | 2016 | 67 | 0.120 |
Why?
| Peer Review, Research | 1 | 2016 | 13 | 0.120 |
Why?
| Hypersensitivity | 2 | 2008 | 76 | 0.120 |
Why?
| Anesthesia, Conduction | 1 | 2016 | 16 | 0.120 |
Why?
| Congresses as Topic | 1 | 2016 | 47 | 0.120 |
Why?
| Risk Reduction Behavior | 1 | 2016 | 58 | 0.120 |
Why?
| Prescription Drug Misuse | 1 | 2016 | 34 | 0.120 |
Why?
| Hemoglobins | 1 | 2016 | 112 | 0.120 |
Why?
| Hyperalgesia | 1 | 2016 | 56 | 0.120 |
Why?
| Chronic Disease | 1 | 2018 | 573 | 0.120 |
Why?
| Ambulatory Care Facilities | 1 | 2016 | 121 | 0.120 |
Why?
| Pneumonia | 1 | 2016 | 124 | 0.120 |
Why?
| Injections, Epidural | 1 | 2015 | 10 | 0.120 |
Why?
| Liposomes | 1 | 2015 | 52 | 0.120 |
Why?
| Arthroplasty, Replacement, Ankle | 1 | 2014 | 3 | 0.120 |
Why?
| Multivariate Analysis | 1 | 2016 | 583 | 0.120 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 120 | 0.110 |
Why?
| Follow-Up Studies | 3 | 2020 | 2231 | 0.110 |
Why?
| Smoking | 1 | 2018 | 506 | 0.110 |
Why?
| Anesthetics, Local | 1 | 2015 | 76 | 0.110 |
Why?
| Delivery of Health Care | 1 | 2017 | 305 | 0.110 |
Why?
| Age Factors | 1 | 2017 | 1118 | 0.110 |
Why?
| Bacteria | 1 | 2015 | 210 | 0.110 |
Why?
| Diabetes Mellitus | 1 | 2017 | 281 | 0.110 |
Why?
| Drug Overdose | 1 | 2016 | 162 | 0.110 |
Why?
| Arthropod Proteins | 1 | 2013 | 1 | 0.100 |
Why?
| Antigens, Dermatophagoides | 1 | 2013 | 3 | 0.100 |
Why?
| Humeral Fractures | 1 | 1992 | 8 | 0.100 |
Why?
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2013 | 9 | 0.100 |
Why?
| Cysteine Endopeptidases | 1 | 2013 | 67 | 0.100 |
Why?
| Child | 9 | 2020 | 6931 | 0.100 |
Why?
| Venous Thrombosis | 1 | 2014 | 86 | 0.100 |
Why?
| Interferon-beta | 1 | 2013 | 28 | 0.100 |
Why?
| Joint Prosthesis | 1 | 1992 | 12 | 0.100 |
Why?
| Patient Positioning | 1 | 2013 | 31 | 0.100 |
Why?
| Mass Screening | 1 | 2016 | 343 | 0.100 |
Why?
| Pulmonary Embolism | 1 | 2014 | 99 | 0.100 |
Why?
| Environmental Monitoring | 1 | 2013 | 66 | 0.100 |
Why?
| Acute Kidney Injury | 1 | 2016 | 302 | 0.100 |
Why?
| Child, Preschool | 7 | 2016 | 3953 | 0.100 |
Why?
| Carpal Bones | 1 | 1992 | 2 | 0.100 |
Why?
| Synostosis | 1 | 1992 | 2 | 0.100 |
Why?
| Glycoproteins | 1 | 2013 | 116 | 0.100 |
Why?
| Diseases in Twins | 1 | 1992 | 14 | 0.100 |
Why?
| Ambulatory Care | 1 | 2014 | 243 | 0.100 |
Why?
| Fungal Proteins | 1 | 2013 | 119 | 0.090 |
Why?
| Arm Injuries | 1 | 1991 | 11 | 0.090 |
Why?
| Tibia | 2 | 2023 | 119 | 0.090 |
Why?
| Socioeconomic Factors | 3 | 2023 | 591 | 0.090 |
Why?
| Aging | 1 | 1996 | 692 | 0.090 |
Why?
| Immune Evasion | 2 | 2021 | 11 | 0.090 |
Why?
| Lidocaine | 1 | 1991 | 48 | 0.090 |
Why?
| Immunoglobulin E | 2 | 2016 | 91 | 0.090 |
Why?
| Epitopes, B-Lymphocyte | 2 | 2021 | 4 | 0.090 |
Why?
| Stroke | 1 | 2016 | 495 | 0.090 |
Why?
| Protein Binding | 3 | 2021 | 648 | 0.090 |
Why?
| Nerve Block | 1 | 1991 | 42 | 0.090 |
Why?
| Antigens, Viral | 2 | 2021 | 42 | 0.090 |
Why?
| Immunoglobulin A | 2 | 2021 | 44 | 0.090 |
Why?
| Mental Disorders | 1 | 2016 | 418 | 0.090 |
Why?
| Osteoclasts | 2 | 2024 | 427 | 0.090 |
Why?
| Mycotoxins | 2 | 2008 | 12 | 0.090 |
Why?
| Fatigue | 2 | 2021 | 127 | 0.090 |
Why?
| Immunoglobulin M | 2 | 2021 | 58 | 0.090 |
Why?
| Sleep | 2 | 2021 | 183 | 0.080 |
Why?
| Cohort Studies | 3 | 2021 | 1451 | 0.080 |
Why?
| Quality of Life | 3 | 2022 | 850 | 0.080 |
Why?
| Arthrometry, Articular | 1 | 2009 | 1 | 0.080 |
Why?
| Obesity | 1 | 2017 | 1123 | 0.080 |
Why?
| Cell Line, Tumor | 4 | 2024 | 1393 | 0.080 |
Why?
| Kinetics | 2 | 2021 | 634 | 0.080 |
Why?
| Transcriptional Activation | 2 | 2006 | 120 | 0.080 |
Why?
| Prospective Studies | 3 | 2025 | 2378 | 0.070 |
Why?
| Gene Expression Profiling | 2 | 2024 | 1020 | 0.070 |
Why?
| Phylogeny | 2 | 2021 | 195 | 0.070 |
Why?
| Environmental Illness | 1 | 2007 | 1 | 0.070 |
Why?
| Sick Building Syndrome | 1 | 2007 | 1 | 0.070 |
Why?
| Phosphorylation | 3 | 2006 | 520 | 0.070 |
Why?
| Muscle, Skeletal | 2 | 2022 | 786 | 0.070 |
Why?
| Propensity Score | 2 | 2017 | 136 | 0.070 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2005 | 200 | 0.070 |
Why?
| Inflammation | 2 | 2022 | 607 | 0.060 |
Why?
| Disability Evaluation | 2 | 2019 | 92 | 0.060 |
Why?
| Algorithms | 2 | 2014 | 624 | 0.060 |
Why?
| Hospitalization | 2 | 2020 | 677 | 0.060 |
Why?
| Air | 1 | 2005 | 22 | 0.060 |
Why?
| Homeodomain Proteins | 1 | 2005 | 79 | 0.060 |
Why?
| Infusions, Subcutaneous | 1 | 2025 | 3 | 0.060 |
Why?
| Polyethylenes | 2 | 2023 | 13 | 0.060 |
Why?
| Practice Guidelines as Topic | 2 | 2020 | 473 | 0.060 |
Why?
| Kansas | 2 | 2014 | 7 | 0.060 |
Why?
| Prospective Payment System | 1 | 2024 | 5 | 0.060 |
Why?
| 5-Methoxytryptamine | 1 | 1994 | 2 | 0.060 |
Why?
| Hydroxyindoleacetic Acid | 1 | 1994 | 8 | 0.060 |
Why?
| Receptor, IGF Type 1 | 1 | 2004 | 21 | 0.060 |
Why?
| Embryonic and Fetal Development | 1 | 1994 | 19 | 0.060 |
Why?
| Blastocyst | 1 | 1994 | 10 | 0.060 |
Why?
| Abnormalities, Drug-Induced | 1 | 1994 | 18 | 0.050 |
Why?
| Melatonin | 1 | 1994 | 15 | 0.050 |
Why?
| Injury Severity Score | 2 | 2002 | 165 | 0.050 |
Why?
| Spinal Nerves | 1 | 2003 | 11 | 0.050 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2004 | 44 | 0.050 |
Why?
| Humerus | 1 | 2003 | 18 | 0.050 |
Why?
| Fetal Diseases | 1 | 1994 | 57 | 0.050 |
Why?
| Quality Indicators, Health Care | 1 | 2024 | 87 | 0.050 |
Why?
| Health Status | 1 | 2005 | 298 | 0.050 |
Why?
| Bone Screws | 1 | 2003 | 33 | 0.050 |
Why?
| Receptors, Estrogen | 1 | 2004 | 132 | 0.050 |
Why?
| Axilla | 1 | 2003 | 92 | 0.050 |
Why?
| Arkansas | 2 | 2019 | 1974 | 0.050 |
Why?
| Nitric Oxide | 1 | 2005 | 253 | 0.050 |
Why?
| International Classification of Diseases | 1 | 2023 | 64 | 0.050 |
Why?
| Tumor Microenvironment | 1 | 2024 | 221 | 0.050 |
Why?
| Tertiary Care Centers | 1 | 2023 | 78 | 0.050 |
Why?
| Cell Membrane | 1 | 2004 | 247 | 0.050 |
Why?
| Transplantation, Homologous | 1 | 2023 | 146 | 0.050 |
Why?
| Ion Channels | 1 | 2023 | 74 | 0.050 |
Why?
| Magnetic Resonance Imaging | 2 | 2014 | 1546 | 0.050 |
Why?
| Confidence Intervals | 1 | 2002 | 155 | 0.050 |
Why?
| Administration, Oral | 1 | 2023 | 438 | 0.050 |
Why?
| Angiography | 1 | 2002 | 128 | 0.050 |
Why?
| Transcriptome | 1 | 2024 | 314 | 0.050 |
Why?
| Transcription Factors | 1 | 2005 | 561 | 0.050 |
Why?
| Health Status Indicators | 1 | 2002 | 83 | 0.050 |
Why?
| Benchmarking | 1 | 2022 | 63 | 0.050 |
Why?
| RNA Helicases | 1 | 2002 | 30 | 0.050 |
Why?
| Muscles | 1 | 2022 | 104 | 0.050 |
Why?
| New York | 1 | 2021 | 47 | 0.050 |
Why?
| Chromium | 1 | 2021 | 4 | 0.050 |
Why?
| Femur Neck | 1 | 2021 | 6 | 0.050 |
Why?
| Leg | 1 | 2022 | 123 | 0.050 |
Why?
| Cobalt | 1 | 2021 | 16 | 0.050 |
Why?
| Personnel Staffing and Scheduling | 1 | 2021 | 21 | 0.050 |
Why?
| Antigen-Antibody Reactions | 1 | 2021 | 16 | 0.050 |
Why?
| Back | 1 | 2021 | 5 | 0.050 |
Why?
| Antigen-Antibody Complex | 1 | 2021 | 35 | 0.050 |
Why?
| Thrombectomy | 1 | 2002 | 72 | 0.050 |
Why?
| Fibrosis | 1 | 2022 | 181 | 0.050 |
Why?
| Protein Structure, Quaternary | 1 | 2021 | 27 | 0.050 |
Why?
| Immunoglobulin Variable Region | 1 | 2021 | 15 | 0.050 |
Why?
| Torso | 1 | 2021 | 15 | 0.050 |
Why?
| Fracture Fixation, Internal | 1 | 2021 | 39 | 0.050 |
Why?
| Tumor Cells, Cultured | 1 | 2002 | 453 | 0.050 |
Why?
| Somatic Hypermutation, Immunoglobulin | 1 | 2021 | 4 | 0.050 |
Why?
| HLA Antigens | 1 | 2021 | 52 | 0.050 |
Why?
| Indoles | 1 | 1994 | 277 | 0.040 |
Why?
| Genome, Viral | 1 | 2021 | 73 | 0.040 |
Why?
| Directed Molecular Evolution | 1 | 2020 | 1 | 0.040 |
Why?
| Protein Conformation | 1 | 2021 | 163 | 0.040 |
Why?
| Immunization, Secondary | 1 | 2021 | 21 | 0.040 |
Why?
| Protein Multimerization | 1 | 2021 | 50 | 0.040 |
Why?
| Workplace | 1 | 2021 | 94 | 0.040 |
Why?
| Government | 1 | 2020 | 2 | 0.040 |
Why?
| Crystallography, X-Ray | 1 | 2021 | 145 | 0.040 |
Why?
| Fluorescent Antibody Technique | 1 | 2021 | 109 | 0.040 |
Why?
| Protein Engineering | 1 | 2020 | 17 | 0.040 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 227 | 0.040 |
Why?
| Virulence | 1 | 2021 | 160 | 0.040 |
Why?
| Femur Head | 1 | 2020 | 25 | 0.040 |
Why?
| Bone Transplantation | 1 | 2020 | 43 | 0.040 |
Why?
| Endothelial Cells | 1 | 2022 | 256 | 0.040 |
Why?
| Psychological Theory | 1 | 2020 | 25 | 0.040 |
Why?
| Cefazolin | 1 | 2020 | 10 | 0.040 |
Why?
| North America | 1 | 2020 | 65 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2021 | 87 | 0.040 |
Why?
| Wounds and Injuries | 1 | 2004 | 288 | 0.040 |
Why?
| Penicillins | 1 | 2020 | 29 | 0.040 |
Why?
| Cricetinae | 1 | 2020 | 207 | 0.040 |
Why?
| Binding Sites | 1 | 2021 | 362 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2002 | 855 | 0.040 |
Why?
| Dependovirus | 1 | 2021 | 102 | 0.040 |
Why?
| Salvage Therapy | 1 | 2021 | 137 | 0.040 |
Why?
| Structure-Activity Relationship | 1 | 2021 | 391 | 0.040 |
Why?
| Operating Rooms | 1 | 2020 | 27 | 0.040 |
Why?
| Osteoblasts | 1 | 2023 | 463 | 0.040 |
Why?
| DNA Helicases | 1 | 2002 | 147 | 0.040 |
Why?
| Predictive Value of Tests | 1 | 2002 | 924 | 0.040 |
Why?
| Aftercare | 1 | 2020 | 72 | 0.040 |
Why?
| Infection Control | 1 | 2020 | 47 | 0.040 |
Why?
| Patella | 1 | 2019 | 13 | 0.040 |
Why?
| Intestines | 1 | 2021 | 152 | 0.040 |
Why?
| Heel | 1 | 2019 | 5 | 0.040 |
Why?
| Shoes | 1 | 2019 | 11 | 0.040 |
Why?
| Sutures | 1 | 2019 | 42 | 0.040 |
Why?
| Bone and Bones | 1 | 2023 | 481 | 0.040 |
Why?
| Software | 1 | 2021 | 268 | 0.040 |
Why?
| Time and Motion Studies | 1 | 2019 | 11 | 0.040 |
Why?
| Sports Equipment | 1 | 2019 | 4 | 0.040 |
Why?
| Body Weight | 1 | 2021 | 517 | 0.040 |
Why?
| Telephone | 1 | 2019 | 68 | 0.040 |
Why?
| Biopsy | 1 | 2021 | 588 | 0.040 |
Why?
| Electronic Health Records | 1 | 2021 | 222 | 0.040 |
Why?
| Quality Assurance, Health Care | 1 | 2019 | 149 | 0.040 |
Why?
| Referral and Consultation | 1 | 2020 | 287 | 0.040 |
Why?
| Morphine | 1 | 2018 | 104 | 0.040 |
Why?
| Linear Models | 1 | 2018 | 283 | 0.030 |
Why?
| Molecular Weight | 1 | 2017 | 82 | 0.030 |
Why?
| Macadamia | 1 | 2016 | 1 | 0.030 |
Why?
| Probability | 1 | 2016 | 163 | 0.030 |
Why?
| Disease Models, Animal | 1 | 2021 | 1431 | 0.030 |
Why?
| Protein Array Analysis | 1 | 2015 | 23 | 0.030 |
Why?
| Genes, Bacterial | 1 | 2015 | 44 | 0.030 |
Why?
| Case-Control Studies | 1 | 2019 | 1152 | 0.030 |
Why?
| Mice, Inbred C57BL | 1 | 2021 | 1796 | 0.030 |
Why?
| RNA, Ribosomal, 16S | 1 | 2015 | 108 | 0.030 |
Why?
| Emergency Service, Hospital | 1 | 2019 | 489 | 0.030 |
Why?
| Corrosion | 1 | 2014 | 4 | 0.030 |
Why?
| Urban Population | 1 | 2015 | 150 | 0.030 |
Why?
| Ions | 1 | 2014 | 31 | 0.030 |
Why?
| Metals | 1 | 2014 | 34 | 0.030 |
Why?
| Prevalence | 2 | 2014 | 967 | 0.030 |
Why?
| Injections, Intramuscular | 1 | 2013 | 49 | 0.030 |
Why?
| Atrophy | 1 | 2013 | 40 | 0.030 |
Why?
| Twins, Monozygotic | 1 | 1992 | 15 | 0.020 |
Why?
| Thrombophlebitis | 1 | 1992 | 24 | 0.020 |
Why?
| Arthritis, Rheumatoid | 1 | 1992 | 108 | 0.020 |
Why?
| Vena Cava Filters | 1 | 1992 | 33 | 0.020 |
Why?
| Injections, Intravenous | 1 | 1991 | 137 | 0.020 |
Why?
| Prognosis | 1 | 1996 | 1974 | 0.020 |
Why?
| Pelvic Bones | 1 | 1990 | 12 | 0.020 |
Why?
| Dextrans | 1 | 1990 | 17 | 0.020 |
Why?
| Clinical Trials as Topic | 1 | 2013 | 488 | 0.020 |
Why?
| Cognition | 1 | 2013 | 342 | 0.020 |
Why?
| Risk Assessment | 1 | 2014 | 1268 | 0.020 |
Why?
| Thromboembolism | 1 | 1990 | 54 | 0.020 |
Why?
| Leg Injuries | 1 | 1989 | 12 | 0.020 |
Why?
| Irritants | 1 | 2008 | 1 | 0.020 |
Why?
| Ergosterol | 1 | 2008 | 10 | 0.020 |
Why?
| Glucans | 1 | 2008 | 10 | 0.020 |
Why?
| Surgical Flaps | 1 | 1989 | 110 | 0.020 |
Why?
| p21-Activated Kinases | 1 | 2006 | 4 | 0.020 |
Why?
| LIM Domain Proteins | 1 | 2005 | 8 | 0.020 |
Why?
| Serine | 1 | 2006 | 38 | 0.020 |
Why?
| Tamoxifen | 1 | 2006 | 61 | 0.020 |
Why?
| Estrogen Receptor beta | 1 | 2005 | 56 | 0.020 |
Why?
| HeLa Cells | 1 | 2006 | 257 | 0.010 |
Why?
| Histone Deacetylases | 1 | 2005 | 51 | 0.010 |
Why?
| Cotinine | 1 | 2005 | 21 | 0.010 |
Why?
| Chromatin | 1 | 2005 | 133 | 0.010 |
Why?
| Trans-Activators | 1 | 2005 | 135 | 0.010 |
Why?
| Brain | 1 | 2013 | 1318 | 0.010 |
Why?
| Repressor Proteins | 1 | 2005 | 149 | 0.010 |
Why?
| Up-Regulation | 1 | 2006 | 446 | 0.010 |
Why?
| Macromolecular Substances | 1 | 2004 | 36 | 0.010 |
Why?
| Fetal Resorption | 1 | 1994 | 2 | 0.010 |
Why?
| Shc Signaling Adaptor Proteins | 1 | 2004 | 21 | 0.010 |
Why?
| Pineal Gland | 1 | 1994 | 8 | 0.010 |
Why?
| Fetal Death | 1 | 1994 | 20 | 0.010 |
Why?
| Organ Culture Techniques | 1 | 1994 | 47 | 0.010 |
Why?
| Nicotine | 1 | 2005 | 184 | 0.010 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2004 | 154 | 0.010 |
Why?
| RNA, Small Interfering | 1 | 2004 | 208 | 0.010 |
Why?
| RNA Interference | 1 | 2004 | 179 | 0.010 |
Why?
| Organ Size | 1 | 1994 | 225 | 0.010 |
Why?
| Protein Transport | 1 | 2004 | 183 | 0.010 |
Why?
| Fetus | 1 | 1994 | 184 | 0.010 |
Why?
| Estradiol | 1 | 2004 | 221 | 0.010 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2005 | 831 | 0.010 |
Why?
| Phlebography | 2 | 1992 | 60 | 0.010 |
Why?
| Signal Transduction | 1 | 2006 | 1608 | 0.010 |
Why?
| Pregnancy | 1 | 1994 | 2444 | 0.010 |
Why?
| Prothrombin Time | 1 | 1992 | 18 | 0.010 |
Why?
| Drug Monitoring | 1 | 1992 | 81 | 0.010 |
Why?
| Warfarin | 1 | 1992 | 82 | 0.010 |
Why?
| Urogenital System | 1 | 1990 | 5 | 0.010 |
Why?
| Multiple Trauma | 1 | 1990 | 32 | 0.010 |
Why?
| Femoral Neck Fractures | 1 | 1990 | 7 | 0.010 |
Why?
| Combined Modality Therapy | 1 | 1992 | 640 | 0.010 |
Why?
|
|
Barnes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|